|
Financial & Legal |
|
Erectile Dysfunction / Premature Ejaculation News From Medical News Today
|
Latest Health News and Medical News posted throughout the day, every day.
|
-
Many Older Adults With Diabetes Are Sexually Active But Have Problems
New research from the University of Chicago found that many middle-aged and older Americans with diabetes are sexually active but more likely to experience sexual problems compared with counterparts without diabetes...
-
Palatin Technologies, Inc. Announces Positive Safety Results In Subcutaneous Bremelanotide Trial In Men
Palatin Technologies, Inc. (NYSE Amex: PTN) announced positive results of a Phase 1 clinical trial of subcutaneously administered bremelanotide, its melanocortin agonist drug candidate for treatment of male erectile dysfunction (ED) and female sexual dysfunction (FSD)...
-
Novacare LLC Conducts Voluntary Nationwide Recall Of Products Found To Contain Undeclared Drug Ingredient
Novacare LLC has announced that it is conducting a voluntary nationwide recall of products sold under the following names: Stiff Nights, Aziffa, Size Matters, Erex, Mojo, Hard Drive, Eyeful, Red Magic, Straight Up, Zotrex, Monster Excyte, WOW, Xaitrex, Verect, Prolatis, Xytamax, Maxyte, Libidinal, OMG, OMG45, and Zilex (with Golden Spear)...
-
EZVille, Ltd. Issues A Voluntary Nationwide Recall Of Revivexxx® Extra Strength Found To Contain An Undeclared Drug Ingredient
EZVille, Ltd. of Ronkonkoma, NY, has been informed by the US Food and Drug Administration (FDA) that FDA lab analysis of Revivexxx® Extra Strength distributed by the company was found to contain undeclared tadalafil. Tadalafil is an FDA-approved drug for the treatment of male Erectile Dysfunction (ED), making Revivexxx® Extra Strength an unapproved drug...
-
Laser May Reduce Prostate Surgery's Long-Term Erectile Dysfunction
One of the challenges of prostate cancer surgery is removing the cancer-affected gland without side effects. The procedure is estimated to cause long-term sexual dysfunction in half of men...
-
Peyronie's Disease Following Radical Prostatectomy: Incidence And Predictors
UroToday.com - Peyronie's disease (PD) occurs more frequently following radical prostatectomy (RP) than it does among men in the general population, according to a report by Dr. Raanan Tal and colleagues in the Journal of Sexual Medicine. In the general population, the incidence of PD is reported to be 3.2-8.9%...
-
The Future Is Today: Emerging Drugs For The Treatment Of Erectile Dysfunction
UroToday.com - Erectile Dysfunction (ED) is the most common male sexual dysfunction presented for treatment, and the most thoroughly studied sexual dysfunction in men. In the late 20th century, important discoveries were made regarding both the physiologic processes of penile erection and the pathophysiology of ED...
-
Federal Agents Seize FastSize Extenders And FastSize EQM Erectile Quality Monitors
At the request of the U.S. Food and Drug Administration, U.S. Marshals seized $346,954.43 worth of FastSize Extender devices and FastSize EQM Erectile Quality Monitor devices, as well as component parts used in the manufacture of the FastSize Extender. The FastSize Extender and the FastSize EQM Erectile Quality Monitor are manufactured and distributed by FastSize, LLC of Aliso Viejo, Calif...
-
Dangers Of Untreated Erectile Dysfunction
Research carried out by a visiting professor at the University of Hertfordshire has found that up to six million European men fail to seek help for Erectile Dysfunction (ED) which could result in underlying cardiovascular disease going undetected...
-
Increased Risk Of Cardiovascular Problems In Depressed Men With Erectile Dysfunction
A new study in the Journal of Sexual Medicine found that the presence of depressive symptoms in men with erectile dysfunction constitutes a risk factor for a major cardiovascular event. Erectile dysfunction and depressive mood are often associated, and both are associated with an increased risk of cardiovascular disease and death...
|
|
News & Information 
